Actinium Pharmaceuticals, Inc. ATNM
1.43 USD +0.13 (+10.00%)
At closeNov 6, 2026, 6:01 PM EST
1.45 +0.02 +1.40%
After hours · Nov 6, 6:01 PM ET
1.30 Day range 1.43
0.749 52-week range 1.69
- YTD
- +5.15%
- 1 year
- +8.33%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 90.00K | 0 | 81.00K | 1.03M | 1.14M | |
| 90.00K | 0 | 81.00K | 1.03M | 1.14M | |
| -36.25M | -42.12M | -51.92M | -34.10M | -24.96M | |
| -33.89M | -38.24M | -48.82M | -33.02M | -24.77M | |
| -1.09 | -1.27 | -1.83 | -1.37 | -1.20 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 48.00M | 72.90M | 76.68M | 109.31M | 78.22M | |
| 51.77M | 76.90M | 81.44M | 114.19M | 80.39M | |
| 43.94M | 44.14M | 45.07M | 47.71M | 6.84M | |
| 1.69M | 1.57M | 2.11M | 2.58M | 310.00K | |
| 7.83M | 32.76M | 36.38M | 66.48M | 73.55M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -24.58M | -33.07M | -47.34M | 8.64M | -20.87M | |
| -104.00K | -11.00K | -153.00K | -366.00K | -133.00K | |
| -217.00K | 29.32M | 14.87M | 23.11M | 35.22M | |
| -104.00K | -11.00K | -153.00K | -366.00K | -133.00K | |
| -24.89M | -3.76M | -32.62M | 31.39M | 14.22M |